2841
543277
LXCHEM
Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply
As of the latest trading session, LAXMI ORGANIC INDUS LTD share price is currently at ₹ 187.9, which is up by ₹ 0.84 from its previous closing. Today, the stock has fluctuated between ₹ 186.10 and ₹ 190.02. Over the past year, LAXMI ORGANIC INDUS LTD has achieved a return of -25.96 %. In the last month alone, the return has been -6.79 %. Read More...
Smart Investing Starts here !
Trade Smart with Fast Execution & Zero Account Opening Fees
Invest Now
| Particulars | SEP 2025 (Values in Cr) |
|---|---|
| Revenue | 706.42 |
| Operating Expense | 691.46 |
| Net Profit | 13.94 |
| Net Profit Margin (%) | 1.97 |
| Earnings Per Share (EPS) | 0.50 |
| EBITDA | 43.87 |
| Effective Tax Rate (%) | 26.08 |
| Company Name | Price | P/E | P/B | Market Cap | 52 Week Low/High |
|---|---|---|---|---|---|
| ATUL LTD | 5915.15 | 32.12 | 2.94 | 17415.24 | 4882.00 / 7793.00 |
| BASF INDIA LTD | 4413.25 | 49.03 | 5.25 | 19103.04 | 4076.75 / 6629.15 |
| ORIENTAL AROMATICS LTD | 338.65 | 116.37 | 1.72 | 1139.68 | 252.40 / 570.05 |
| DEEPAK FERTILIZERS & PETR | 1411.05 | 18.10 | 2.73 | 17812.79 | 888.25 / 1776.95 |
| Company Name | Price | P/E | P/B | Market Cap | 52 Week Low/High |
|---|---|---|---|---|---|
| ADVANCE PETROCHEMICALS LTD. | 190.20 | 345.82 | 4.60 | 17.12 | 168.70 / 283.35 |
| ATUL LTD | 5915.15 | 35.66 | 2.99 | 17415.24 | 4882.00 / 7793.00 |
| BASF INDIA LTD | 4413.25 | 46.41 | 5.22 | 19103.04 | 4076.75 / 6629.15 |
| ORIENTAL AROMATICS LTD | 338.65 | 36.34 | 1.65 | 1139.68 | 252.40 / 570.05 |
Choose a Plan That Suits Your Goals and Needs
-19 (-4.73%)
-2 (-0.92%)
-96 (-0.81%)
-19 (-0.64%)
-1 (-0.63%)
Revenue stood at ₹693 crore in Q1 FY25-26, compared to ₹718 crore in Q1 FY24-25. Operating profit was ₹31 crore in Q1 FY25-26, lower than ₹71 crore in Q1 FY24-25. Net profit came in at ₹21 crore in Q1 FY25-26 versus ₹34 crore in Q1 FY24-25. The operating margin stood at 4% in Q1 FY25-26, down from 10% in Q1 FY24-25. These figures reflect the company’s performance for the quarter ended June 30, 2025.
Laxmi Organic’s annual results for FY24-25 show sales of ₹2,985 crore compared with ₹2,865 crore in FY23-24. Operating profit rose to ₹286 crore in FY24-25 from ₹256 crore in FY23-24, with margins steady at 10%. Profit for the period was ₹114 crore in FY24-25 against ₹121 crore in FY23-24. These results summarise the company’s performance.
Between July 2021 and July 2025, the company has declared annual dividends in the range of ₹0.50 to ₹0.70 per share. For the financial year 2024–25, a dividend of ₹0.50 per share was announced with an ex-date of July 18, 2025. In the previous year, the dividend was ₹0.60 per share, with an ex-date of July 19, 2024. The dividend for FY23 stood at ₹0.50 per share (ex-date: July 21, 2023), while FY22 saw a payout of ₹0.70 per share (ex-date: July 18, 2022). For FY21, the dividend was ₹0.50 per share with an ex-date of July 14, 2021.
Laxmi Organic Industries Limited stands today as the flagship of the Goenka Group, but its beginnings were moderate. Incorporated in May 1989, the company has built itself into a recognised name in acetyl intermediates and speciality chemicals, serving both domestic and global markets.
In its early phase, the business focused on acetaldehyde and acetic acid, commencing production in 1992. These were core building-block chemicals, the kind that form the backbone of countless downstream industries. By 1996, the company had moved into ethyl acetate manufacturing. That step proved pivotal. Over time, it made Laxmi a large producer of ethyl acetate in India, with around 30% market share in recent years. The addition of Yellowstone Chemicals (YCPL) into its fold was aimed at consolidating this position further, reinforcing a leadership stance in the segment.
The second leg of its journey came in 2010, when Laxmi stepped into speciality intermediates through the acquisition of Clariant’s diketene business. This was not a marginal addition. It gave the company India’s only diketene derivatives platform and an estimated 55% market share by revenue in fiscal 2020. Speciality products often carry higher margins than commodity acetyls, and the diketene line created an entirely new growth runway. Esters, amides, acetic anhydride, arylides — these became part of the expanding product map.
The product split remains broadly twofold: acetyl intermediates on one side, speciality intermediates on the other. Ethyl acetate, acetaldehyde, ethanol, and solvents still anchor the acetyl basket. Speciality intermediates, though, cover ketene and diketene derivatives used in pharmaceuticals, agrochemicals, inks, dyes, coatings, fragrances, and adhesives. In practice, that mix allows the company to tap into sectors with cyclical demand patterns but also sectors with secular growth trends, such as pharma and packaging.
Diversification has not stopped there. In recent years, Laxmi acquired the assets of Miteni in Europe, bringing in capabilities in fluorospecialties and electrochemical fluorination. This move was a deliberate step into higher-margin fluorochemicals, a space where demand is driven by applications in advanced materials and pharma. Frost & Sullivan reports have noted that the combination of acetyl, speciality intermediates, and fluorochemicals could give Laxmi a differentiated positioning compared with most local peers, who tend to be more siloed in product lines.
Geographically, the company has worked to extend its reach. It now serves over 30 countries, from the Netherlands and Russia to Singapore and the United States. International offices in Leiden, Shanghai, and Sharjah, along with third-party storage facilities in Mumbai, Rotterdam, Antwerp, and Genoa, give it a distribution backbone. In practice, this footprint helps reduce delivery times and keeps the company plugged into customer needs abroad.
On the operating side, two manufacturing facilities in Mahad form the production core, one dedicated to acetyl intermediates and the other to speciality intermediates. Together, as of September 2020, these offered a capacity of about 239,000 MTPA. Supporting these are two distilleries in Satara and Kolhapur, producing ethanol for captive use in manufacturing fuel-grade ethanol and downstream products. An additional fluorospecialty facility at Lote Parshuram, Maharashtra, is being set up, signalling the next phase of product build-out.
Research and development have also become more structured. Two DSIR-recognised labs support molecule synthesis and advanced intermediates. More recently, a Global Innovation Centre in Navi Mumbai, commissioned in FY2025, adds scale to R&D efforts.
Ownership and structure have also evolved. Between 2018 and 2020, the company undertook corporate changes, selling its stake in Suvas Holdings, incorporating subsidiaries in India and China, and positioning itself for broader global exposure. The watershed came in March 2021, when Laxmi launched an ₹800 crore IPO. About ₹200 crore was raised via pre-IPO placements with marquee investors such as IIFL, GMO, WhiteOak, and Malabar. The listing on NSE and BSE provided the company with both capital and visibility.
Looking at its present stance, Laxmi Organic is positioned as a diversified chemical player with one foot in bulk intermediates and another in high-value speciality niches. Its global client list includes names across pharma, agrochemicals, dyes, and packaging, suggesting a fairly diversified demand base. With capacity growth, overseas distribution, and R&D scaling, the company’s trajectory appears aligned toward higher-value markets and more defensible margins.
Who is the CEO of Laxmi Organics Ltd?
The CEO of Laxmi Organics Ltd is Dr. Rajan Venkatesh, who was appointed as Managing Director and Chief Executive Officer effective April 3, 2023. Under his guidance, the company has grown significantly, especially in the production of acetyl intermediates and specialty chemicals. His leadership is instrumental in expanding Laxmi Organics' market presence and product portfolio.
When was Laxmi Organics established?
Laxmi Organics Ltd was established in 1989 and has been a prominent player in the manufacturing of acetyl intermediates and specialty chemicals since its inception. The company started its operations with the production of acetaldehyde and acetic acid, later expanding its portfolio to include ethyl acetate, which is now one of its flagship products.
What factors influence the Laxmi Organics share price?
The Laxmi Organics share price is influenced by a range of factors. Key among these are:
Is Laxmi Organics debt-free?
As of now, Laxmi Organics Ltd is not entirely debt-free. The company has taken strategic steps to finance its growth, including raising funds through its Initial Public Offering (IPO) in 2021. However, it has been working on managing and reducing debt levels over time while investing in its infrastructure and expanding its product offerings.
What is the CAGR of Laxmi Organics Share?
The Compound Annual Growth Rate (CAGR) of the Laxmi Organics share price over the past 10 years and 5 years is not specified, but the share has shown a decline of approximately -14% over the last 3 years and a modest -1% over the last year. These figures reflect the volatility in the stock market and the challenges faced by the company in recent years, despite its strong operational performance.
How has the Laxmi Organics Share Price performed over the past year?
The Laxmi Organics share price has seen a slight decline of approximately -1% over the past year. Despite some fluctuations, the stock has remained relatively stable with periodic increases and decreases, largely influenced by broader market trends and internal developments such as acquisitions and new product launches. The share price has recently shown positive momentum, reflecting market confidence in the company’s future growth prospects.
Laxmi Organic Industries Limited is the Goenka Group's flagship company, established in 1989 and is in the business of Acetyl Intermediates and Specialty Chemicals. The Company primarily manufactures Ethyl Acetate, Acetic Acid and Diketene Derivative Products (DDP). DDP is a specialty chemical group, the technology and business of which has been acquired by LOIL from Clariant Chemicals India Limited.
Laxmi Organic Industries Limited was incorporated on May 15, 1989. The Company is a leading manufacturer of Acetyl Intermediates and Specialty Intermediates with almost three decades of experience in large scale manufacturing of chemicals. Since its inception in 1989, the company has been on a journey of transformation. The Company initially started manufacturing acetaldehyde and acetic acid in 1992, and soon thereafter moved on to manufacturing of ethyl acetate in 1996. The Company is currently among the largest manufacturers of ethyl acetate in India with a market share of approximately 30% of the Indian ethyl acetate market. Further, post completion of the YCPL Acquisition, the market share in the ethyl acetate market will be further enhanced. In 2010, the company commenced manufacturing the Specialty Intermediates by acquiring Clariant's diketene business. The Company believes that the diversification of its product portfolio into varied chemistries in Specialty Intermediates has enabled it to create a niche for itself. The Company is the only manufacturer of diketene derivatives in India with a market share of approximately 55 % of the Indian diketene derivatives market in terms of revenue in Fiscal 2020 and one of the largest portfolios of diketene products.
The Company's products are currently divided into two broad categories, namely the Acetyl Intermediates and the Specialty Intermediates. The Acetyl Intermediates include ethyl acetate, acetaldehyde, fuel-grade ethanol and other proprietary solvents, while the Specialty Intermediates comprises of ketene, diketene derivatives namely esters, acetic anhydride, amides, arylides and other chemicals. These products find application in various high-growth industries, including pharmaceuticals, agrochemicals, dyes & pigments, inks & coatings, paints, printing & packaging, flavours & fragrances, adhesives and other industrial applications. The Company also proposes to diversify into manufacturing of specialty fluorochemicals to which end, the company has recently acquired assets including plant & machinery, design and operating paperwork, REACH registrations and patents of Miteni, a manufacturer of organic fluorospecialties and electrochemical fluorination. The Company believes it is well placed to enter into the high margin specialty fluorochemicals space through this acquisition. According to the Frost & Sullivan Report, given its expertise in the Acetyl Intermediates and the Specialty Intermediates segments, its entry into the fluorochemicals space will put the company at a differentiated position from other chemicals manufacturers.
Over the years, the company has significantly expanded its scale of operations and global footprint with customers in over 30 countries including China, Netherlands, Russia, Singapore, United Arab Emirates, United Kingdom and United States of America. The Company has established long-standing relationships with marquee players including Syngenta Asia Pacific Pte. Ltd., Alembic Pharmaceuticals Limited, Covestro (India) Private Limited, Dr. Reddy's Laboratories Limited, Flint Group India Private Limited, Granules India Limited, Hetero Labs Limited, Heubach Colour Private Limited, Hubergroup India Private Limited, Huhtamaki India Limited, Laurus Labs Limited, Macleods Pharmaceuticals Private Limited, Mylan Laboratories Limited, Neuland Laboratories Limited, Parikh Packaging Private Limited, Suven Pharmaceuticals Limited, Colourtex Industries Private Limited, and UPL Limited. The Company has offices in Leiden (Netherlands), Shanghai (China) and Sharjah (United Arab Emirates) which enables it to assess international demand and increase its customer outreach thereby bolstering its product development initiatives. The Company also has arrangements with third parties for usage of storage tanks in inter alia Mumbai for storage of raw materials and finished goods and Rotterdam (Netherlands), Antwerp (Belgium) and Genoa (Italy) for storage of finished products which enables the company to deliver its products on short notice. The Company has been the largest exporter of ethyl acetate from India in the six months ended September 30, 2020 and Fiscals 2020, 2019 and 2018 and one of the largest exporters of ethyl acetate to Europe from India since 2012.
The Company currently has two manufacturing facilities in Mahad, Maharashtra with one facility dedicated to Acetyl Intermediates and another dedicated to Specialty Intermediates, which are strategically located in proximity to several ports and each other. As at September 30, 2020, the aggregate installed production capacity at the AI Manufacturing Facility was 161,320 MTPA, while the aggregate installed production capacity at the SI Manufacturing Facility was 78,045 MTPA. The Company is also in the process of acquiring YCPL, having an aggregate installed production capacity of 10,500 MTPA of acetaldehyde and 29,200 MTPA of ethyl acetate as on September 30, 2020. The Company also has two distilleries located in Satara district (the Jarandeshwar Distillery) and Kolhapur district in Maharashtra (the Panchganga Distillery and together with the Jarandeshwar Distillery) for the manufacturing of ethanol or specially denatured spirit. As at September 30, 2020, the Jarandeshwar Distillery had an installed production capacity of 8,100 KLPA while the Panchganga Distillery had an installed production capacity of 9,112 KLPA. The ethanol manufactured at the Distilleries is primarily consumed at the AI Manufacturing Facility and the SI Manufacturing Facility for the manufacturing of fuel-grade ethanol, ethyl acetate and certain Specialty Intermediates including several downstream products. Further, the company is in the process of setting up a manufacturing facility at Lote Parshuram, Maharashtra for manufacturing fluorospecialty chemicals.
The Company has 2 Department of Scientific and Industrial Research, Government of India (DSIR) recognized research and development facilities, with infrastructure to synthesize specialty molecules and advanced intermediates.
During the year 2018-19, the Hydro Power Project at Yedgaon got commissioned and the power generation for captive consumption was also started. During the year 2018-19, the Company sold 49% of the total equity shares which it held in Suvas Holdings Limited to Mr. Ravi Goenka and Mr. Rajeev Goenka. Hence, Suvas Holdings Limited is no longer an associate / joint-venture of the Company.
During year 2019-20, the Company incorporated its wholly owned subsidiary (WOS), Laxmi Speciality Chemicals (Shanghai) Co.
Limited in China on September 5, 2019. It also incorporated 2 new WOS in India, namely Yellowstone Fine Chemicals Private Limited and Yellowstone Speciality Chemicals Private Limited.
During the year 2020-21, Company came out with and Initial Public Offering (IPO) aggregating to Rs. 8,000 million out of which Rs. 2,000 million was issued as Pre-IPO placements to marquee investors such as IIFL, GMO, WhiteOak, Malabar and Kuber India. The offer was subscribed and eventually, the Company was listed on The National Stock Exchange of India Limited (NSE) and BSE Limited (BSE) on March 25, 2021.
During the year 2021-22, Company acquired 100% equity share capital of Acetyls Holding Private Limited (AHPL) through Share Purchase Agreement dated December 09, 2020 and Prospectus dated March 18, 2021 and accordingly, with this acquisition, AHPL and its wholly owned subsidiary Company, Yellowstone Chemicals Private Limited (YCPL) became subsidiaries of Company w.e.f. October 01, 2021.
During the year 2022-23, the wholly owned subsidiary namely, Acetyls Holding Private Limited (AHPL) and its step-down subsidiary namely, Yellowstone Chemicals Private Limited (YCPL), merged with the Company and accordingly, the Assets and Liabilities of the amalgamating entities got incorporated to and vested in the the Company effective from September 30, 2022.
The Company acquired Clariant Chemicals' ketene/diketene business, integrating 16 products in 2024. The Company commissioned its state-of-the-art Global Innovation Centre in Navi Mumbai in FY2025.
Laxmi Organic Industries Ltd share price is for NSE ₹ 187.90 & for BSE ₹ 0.00 as on Nov 17 2025 03:30 PM.
The market cap of Laxmi Organic Industries Ltd for NSE ₹ 5,205.27 & for BSE ₹ 0.00 as on Nov 17 2025 03:30 PM.
The 52 Week High and Low of Laxmi Organic Industries Ltd for NSE is ₹ 279.90 and ₹ 160.20 and for BSE is ₹ 277.50 and ₹ 160.30.
The 1 year returns on the stock has been -25.96%.
As on Nov 17 2025 03:30 PM the price-to-earnings (PE) ratio for Laxmi Organic Industries Ltd share is 55.94.
As on Nov 17 2025 03:30 PM, the price-to-book (PB) ratio for Laxmi Organic Industries Ltd share is 70.00.
You can trade in Laxmi Organic Industries Ltd shares with Bajaj Broking by opening a demat account.
To buy Laxmi Organic Industries Ltd shares on the Bajaj Broking app, follow these steps:
• Login to the Bajaj Broking App
• Click on the Search Icon
• Search “Laxmi Organic Industries Ltd”
• Click on the BUY icon
• Place a buy order specifying the desired quantity of shares.
• Click BUY again to complete the purchase
No results found
